...
首页> 外文期刊>Biochemical Pharmacology >Inhibition and uncoupling of oxidative phosphorylation by nonsteroidal anti-inflammatory drugs: study in mitochondria, submitochondrial particles, cells, and whole heart.
【24h】

Inhibition and uncoupling of oxidative phosphorylation by nonsteroidal anti-inflammatory drugs: study in mitochondria, submitochondrial particles, cells, and whole heart.

机译:非甾体类抗炎药对氧化磷酸化的抑制和解偶联作用:研究线粒体,线粒体颗粒,细胞和整个心脏。

获取原文
获取原文并翻译 | 示例
           

摘要

The effects of the anti-inflammatory drugs diclofenac, piroxicam, indomethacin, naproxen, nabumetone, nimesulide, and meloxicam on mitochondrial respiration, ATP synthesis, and membrane potential were determined. Except for nabumetone and naproxen, the other drugs stimulated basal and uncoupled respiration, inhibited ATP synthesis, and collapsed membrane potential in mitochondria incubated in the presence of either glutamate + malate or succinate. Plots of membrane potential versus ATP synthesis (or respiration) showed proportional variations in both parameters, induced by different concentrations of nimesulide, meloxicam, piroxicam, or indomethacin, but not by diclofenac. The activity of the adenine nucleotide translocase was blocked by diclofenac and nimesulide; diclofenac also slightly inhibited mitochondrial ATPase activity. Naproxen did not affect any of the mitochondrial parameters measured. Nabumetone inhibited respiration, ATP synthesis, and membrane potential in the presence of glutamate + malate, but not with succinate. NADH oxidation in submitochondrial particles also was inhibited by nabumetone. Nabumetone inhibited O2 uptake in intact cells and in whole heart, whereas the other five drugs stimulated respiration. These observations revealed that in situ mitochondria are an accessible target. Except for diclofenac, a negative inotropic effect on cardiac contractility was induced by the drugs. The data indicated that nimesulide, meloxicam, piroxicam, and indomethacin behaved as mitochondrial uncouplers, whereas nabumetone exerted a specific inhibition of site 1 of the respiratory chain. Diclofenac was an uncoupler too, but it also affected the adenine nucleotide translocase and the H+-ATPase.
机译:确定了抗炎药双氯芬酸,吡罗昔康,吲哚美辛,萘普生,萘丁美酮,尼美舒利和美洛昔康对线粒体呼吸,ATP合成和膜电位的影响。除萘丁美酮和萘普生外,其他药物刺激存在谷氨酸+苹果酸或琥珀酸的线粒体中的基础呼吸和非耦合呼吸,抑制ATP合成并降低线粒体的膜电位。膜电位与ATP合成(或呼吸作用)的关系图显示,这两个参数均成比例地变化,这是由不同浓度的尼美舒利,美洛昔康,吡罗昔康或消炎痛引起的,但不是由双氯芬酸引起的。双氯芬酸和尼美舒利阻断了腺嘌呤核苷酸转位酶的活性。双氯芬酸还略微抑制线粒体ATPase活性。萘普生不影响所测的任何线粒体参数。在谷氨酸+苹果酸存在下,萘丁美酮抑制呼吸作用,ATP合成和膜电位,但琥珀酸则不起作用。萘丁美酮也抑制线粒体颗粒中的NADH氧化。萘丁美酮抑制完整细胞和整个心脏中的O2吸收,而其他五种药物则刺激呼吸。这些观察结果表明,原位线粒体是可接近的靶标。除双氯芬酸外,药物还对心脏收缩产生负性肌力作用。数据表明尼美舒利,美洛昔康,吡罗昔康和吲哚美辛起线粒体解偶联剂的作用,而萘丁美通则对呼吸链的位点1具有特定的抑制作用。双氯芬酸也是解偶联剂,但是它也影响腺嘌呤核苷酸的转位酶和H + -ATP酶。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号